In recent years, quality management has gained increasing importance in healthcare. The field of pathology in particular relies on smooth-running processes and the capability to provide both patients and clinicians with accurate diagnoses, as the specific treatment depends on it.
The âQualitÃ¤tssicherungs-Initiative Pathologieâ (âQuIPÂ®â, Quality Assurance Initiative Pathology) is a joint venture initiated between the Deutsche Gesellschaft fÃ¼r Pathologie e.V. (DGP) (German Society of Pathology) and the Bundesverband Deutscher Pathologen e.V. (German Pathologistsâ Association). Since 2004, the QuIP has been offering round-robin testing services for histopathological, immunohistological and molecular-pathological methods, which serve as external laboratory controls.
As of 2016, it has performed this task as a private limited liability company (GmbH) in order to streamline central processes that had been outsourced up to this point. This is the legal form in which the QuIP intends to get its accreditation to DIN EN ISO 17043 at the earliest possible date. Our service portfolio of round-robin tests is rounded out by advanced training programmes such as PD-L1 diagnostics, as well as individual post-test debriefings by phone. Our work is supported by so-called lead and panel institutes as well as the QuIP board, which provides scientific advice both to the partners and the executive board.